B cell non-Hodgkins lymphoma: experience from a tertiary care cancer center
Annals of Hematology, 05/25/2012
Prakash G et al. – Majority of the patients were treated without rituximab. In comparison to western data, the authors observed higher proportion of DLBCL, lower median age, higher male to female ratio, and higher proportion of patients with B symptoms in the study.